DGX questdiagnostics.com Net earnings per share change in current year
Quest Diagnostics relies on stable demand for core tests, which guarantees a predictable cash flow. Comparing EPS with the same period last year visualizes this resilience, while 14.80 determines the latest valuation metric. Growth is driven by AI laboratory automation algorithms and an extensive network of insurance contracts that ensure customer retention.
Comprehensive metric breakdowns and analytics for Quest Diagnostics (DGX)
- current quotes and average value forecast:
- market capitalization data:
- book value of equity indicators:
- debt and solvency information:
Total Debt to Capital Coefficient Quest Diagnostics|DGX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio questdiagnostics.com|DGX - Company Total Debt|Debt to Net Assets Ratio Quest Corp|DGX - Company Long-Term Debts|Company Short-Term Indebtedness Quest Diagnostics|Interim Coverage Ratio questdiagnostics.com
- earnings and market multiples details:
DGX - Net Profit|Projected Future Earnings Quest Diagnostics|DGX - P/E Multiple|Forward Price to Earnings Multiple Quest Corp|DGX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Quest Corp|DGX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Quest Diagnostics|DGX - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months questdiagnostics.com|DGX - Net earnings per share growth this year|Projected earnings per share increase next year Quest Diagnostics
Summary company analysis:Quest Diagnostics Inc. (DGX)
This indicator measures the annual change in earnings per share, allowing investors to promptly identify a slowdown in capital growth rates between official reports. By analyzing the YoY earnings per share trend, one can assess the monetization efficiency of the massive volumes of laboratory tests performed by Quest Diagnostics (DGX) and paid for by the US healthcare system, which confirms the resilience of the company's fundamental health.
Direct competitors
A - Expected net earnings per share growth this year|Earnings per share growth in current year Illumina Corp|EXAS - Net earnings per share change in current year|Net earnings per share growth this year RVTY (Revvity, Inc.)|Earnings growth in current year bio-rad.com (BIO)|Earnings growth in current year NNNN (Anbio)|Sotera Health Corp (SHC) - Earnings per share growth rate in current year|QDEL - Earnings per share growth in current year|Expected net earnings per share growth this year OPKO Health Corp. OPK|CDNA (caredx.com) - Net earnings per share growth this year|MRVI: Net earnings per one share growth for the current year|Net earnings per share growth this year FLGT|LAB: Earnings per share increase in current year|Earnings growth in current year CTKB|OraSure Corp - Earnings per share growth this year|Earnings growth in current year XGN (Exagen)|Expected net earnings per share growth this year mdxhealth.com (MDXH)|Lucid Diagnostics - Earnings growth in current year|PRE - Earnings growth in current year|IMDX: Earnings growth in current year|Net earnings per share change in current year Trinity Biotech TRIB|Earnings per share growth in current year ProPhase Labs, Inc.|Earnings per share growth this year AIMD (ainos.com)|Earnings per share growth in current year Co-Diagnostics (CODX)|HSCS - Earnings per share growth rate in current year|Earnings per share growth in current year Biomerica, Inc BMRA|Expected net earnings per share growth this year Cardio Diagnostics Holdings Inc. (CDIO)|ONCO: Net earnings per share growth this year|viraxbiolabs.com - Net earnings per one share growth for the current year|BJDX: Earnings growth in current year|AWH - Expected net earnings per share growth this year|AXDX (Accelerate Diagnostics, Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE N.V. (CNTG)|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|Expected net earnings per share growth this year fresh2.co|Earnings growth in current year GENE (Genetic Technologies Limited)|ME: Earnings per share growth this year|Psychemedics Corp - Earnings growth in current year
